DOJ Begins Targeting COVID-19 Fraud Schemes
Client Alert | 1 min read | 03.20.20
In response to increased reporting of COVID-19-related fraud and misconduct, on March 16, 2020 Attorney General Barr directed all U.S. Attorneys to prioritize the prosecution of wrongdoers seeking to profit from this national crisis. Barr stated in his directive that "[t]he pandemic is dangerous enough without wrongdoers seeking to profit from public panic and this sort of conduct cannot be tolerated." Examples of such conduct include the sale of fake cures for COVID-19, phishing emails posing as the World Health Organization or the Centers for Disease Control and Prevention, and malware being inserted into mobile apps designed to track the spread of the virus.
U.S. Attorneys have already started responding to the directive. The U.S. Attorneys in the Western District of Pennsylvania and the Southern District of Mississippi have each appointed a dedicated COVID-19 fraud coordinator, while other U.S. Attorneys have launched hotlines and educational campaigns to combat COVID-19-related fraud. They are joined by other U.S. agencies that are starting to ring similar alarm bells, like the GSA which put out a notice this week that it has received reports of companies fraudulently claiming to be GSA vendors to mislead consumers into paying exorbitant prices for products associated with COVID-19. Over the coming days and weeks, we expect that U.S. Attorneys and agencies across the country will further shift their criminal and civil enforcement priorities to cases stemming from the COVID-19 crisis.
Contacts
Insights
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument.
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
Client Alert | 8 min read | 12.10.25
Creativity You Can Use: CJEU Clarifies Copyright for Applied Art
Client Alert | 4 min read | 12.10.25
Federal Court Strikes Down Interior Order Suspending Wind Energy Development
